Vis AN - Search Results

1

A Systematic Review on the Impact of Quality Assurance Programs on Outcomes after Radical Prostatectomy.

van der Graaf SH, Hagens MJ, Veerman H, Roeleveld TA, Nieuwenhuijzen JA, Wit EMK, W J M Wouters M, van der Mierden S, van Moorselaar RJA, Beerlage HP, Vis AN, van Leeuwen PJ, van der Poel HG. van der Graaf SH, et al. Among authors: vis an. Eur Urol Focus. 2024 Apr 16:S2405-4569(24)00048-8. doi: 10.1016/j.euf.2024.03.004. Online ahead of print. Eur Urol Focus. 2024. PMID: 38631992 Review.

2

Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.

van der Sluis TM, Vis AN, van Moorselaar RJ, Bui HN, Blankenstein MA, Meuleman EJ, Heijboer AC. van der Sluis TM, et al. Among authors: vis an. BJU Int. 2012 Jan;109(2):176-82. doi: 10.1111/j.1464-410X.2011.10651.x. Epub 2011 Oct 12. BJU Int. 2012. PMID: 21992222 Review.

3

Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.

van der Sluis TM, Meuleman EJ, van Moorselaar RJ, Bui HN, Blankenstein MA, Heijboer AC, Vis AN. van der Sluis TM, et al. Among authors: vis an. BJU Int. 2012 Jan;109(2):183-8. doi: 10.1111/j.1464-410X.2011.10652.x. Epub 2011 Oct 12. BJU Int. 2012. PMID: 21992404 Review.

4

Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.

van der Sluis TM, Bui HN, Meuleman EJ, Heijboer AC, Hartman JF, van Adrichem N, Boevé E, de Ronde W, van Moorselaar RJ, Vis AN. van der Sluis TM, et al. Among authors: vis an. J Urol. 2012 May;187(5):1601-6. doi: 10.1016/j.juro.2011.12.063. Epub 2012 Mar 14. J Urol. 2012. PMID: 22425112

5

Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer.

van der Sluis TM, Bijnsdorp IV, Jacobs JJ, Meuleman EJ, Rozendaal L, Geldof AA, van Moorselaar RJ, Vis AN. van der Sluis TM, et al. Among authors: vis an. World J Urol. 2013 Apr;31(2):261-6. doi: 10.1007/s00345-012-0972-4. Epub 2012 Oct 19. World J Urol. 2013. PMID: 23080125

6

Relationship between body mass index and serum testosterone concentration in patients receiving luteinizing hormone-releasing hormone agonist therapy for prostate cancer.

van der Sluis TM, van Moorselaar RJ, Meuleman EJ, ter Haar RW, Bui HN, Heijboer AC, Vis AN. van der Sluis TM, et al. Among authors: vis an. Urology. 2013 May;81(5):1005-9. doi: 10.1016/j.urology.2013.01.014. Epub 2013 Mar 7. Urology. 2013. PMID: 23465153

7

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Roobol MJ, Kranse R, Bangma CH, van Leenders AG, Blijenberg BG, van Schaik RH, Kirkels WJ, Otto SJ, van der Kwast TH, de Koning HJ, Schröder FH; ERSPC Rotterdam Study Group. Roobol MJ, et al. Eur Urol. 2013 Oct;64(4):530-9. doi: 10.1016/j.eururo.2013.05.030. Epub 2013 May 25. Eur Urol. 2013. PMID: 23759326 Clinical Trial.

8

Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?

Vis AN, van der Sluis TM, Al-Itejawi HHM, van Moorselaar RJA, Meuleman EJH. Vis AN, et al. Urol Oncol. 2015 Jan;33(1):7-15. doi: 10.1016/j.urolonc.2014.04.016. Epub 2014 Aug 20. Urol Oncol. 2015. PMID: 25159013 Review.

9

Development of a patient decision aid for the treatment of localised prostate cancer: a participatory design approach.

Al-Itejawi HH, van Uden-Kraan CF, Vis AN, Nieuwenhuijzen JA, Hofstee MJ, van Moorselaar RJ, Verdonck-de Leeuw IM. Al-Itejawi HH, et al. Among authors: vis an. J Clin Nurs. 2016 Apr;25(7-8):1131-44. doi: 10.1111/jocn.13120. Epub 2016 Feb 16. J Clin Nurs. 2016. PMID: 26880526

10

Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer.

Bosschieter J, Vis AN, van der Poel HG, Moonen LM, Horenblas S, van Rhijn BWG, Pieters BR, Nieuwenhuijzen JA, Hendricksen K. Bosschieter J, et al. Among authors: vis an. Eur Urol. 2018 Sep;74(3):369-375. doi: 10.1016/j.eururo.2017.05.054. Epub 2017 Jun 12. Eur Urol. 2018. PMID: 28619396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page